DE69621132D1 - Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa - Google Patents
Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosaInfo
- Publication number
- DE69621132D1 DE69621132D1 DE69621132T DE69621132T DE69621132D1 DE 69621132 D1 DE69621132 D1 DE 69621132D1 DE 69621132 T DE69621132 T DE 69621132T DE 69621132 T DE69621132 T DE 69621132T DE 69621132 D1 DE69621132 D1 DE 69621132D1
- Authority
- DE
- Germany
- Prior art keywords
- hyaluronic acid
- pct
- nsaid
- producing
- medicinal product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Inorganic Chemistry (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002154103A CA2154103C (en) | 1995-07-18 | 1995-07-18 | Treatment of mucous membrane disease, trauma or condition and for the relief of pain |
PCT/CA1996/000488 WO1997003699A1 (en) | 1995-07-18 | 1996-07-18 | Use of hyaluronic acid and a nsaid for the manufacture of a medicament for the treatment of mucosal diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69621132D1 true DE69621132D1 (de) | 2002-06-13 |
DE69621132T2 DE69621132T2 (de) | 2002-10-31 |
Family
ID=4156246
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69621132T Expired - Lifetime DE69621132T2 (de) | 1995-07-18 | 1996-07-18 | Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa |
Country Status (10)
Country | Link |
---|---|
US (1) | US6159955A (de) |
EP (1) | EP0839052B1 (de) |
JP (1) | JP4194653B2 (de) |
AT (1) | ATE217197T1 (de) |
AU (1) | AU719257B2 (de) |
CA (1) | CA2154103C (de) |
DE (1) | DE69621132T2 (de) |
ES (1) | ES2176468T3 (de) |
NZ (1) | NZ312073A (de) |
WO (1) | WO1997003699A1 (de) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6875753B1 (en) | 1996-03-14 | 2005-04-05 | The Governors Of The University Of Alberta | Methods for cell mobilization using in vivo treatment with hyaluronan (HA) |
US5981499A (en) * | 1998-02-20 | 1999-11-09 | Atlantic Biomed Corporation | Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa |
DE69916643T2 (de) * | 1998-10-22 | 2005-04-28 | Bioniche Life Sciences Inc., London | Verwendung von hyaluronsäure zur behandlung der bestrahlungs-blasenentzündung |
US7635489B2 (en) * | 2001-05-18 | 2009-12-22 | Leneau Holdings, Llc | Ingestion of hyaluronic acid for improved joint health |
US6607745B2 (en) | 2001-05-18 | 2003-08-19 | Harry Leneau | Ingestion of hyaluronic acid for improved joint function and health |
ITBO20010361A1 (it) * | 2001-06-07 | 2002-12-07 | Farma Derma S R L | Uso di acido ialuronico per la produzione di un preparato ad uso vaginale, in particolare per la cura degli stati atrofici e distrofici cerv |
KR20050005466A (ko) * | 2002-05-06 | 2005-01-13 | 콜라제넥스 파마슈티칼스, 인크 | 점막염 및 진균 감염을 동시에 치료하는 방법 |
TR200201556A2 (tr) * | 2002-06-12 | 2004-01-21 | Orva İlaç Sanayi̇ Ve Ti̇caret A. Ş. | Kortikosteroid ve nonsteroidal antienflamatuar içeren farmasötik bileşim |
US8377906B2 (en) * | 2004-06-04 | 2013-02-19 | Ethicon, Inc. | Compositions and methods for preventing or reducing postoperative ileus and gastric stasis |
US8129359B2 (en) * | 2004-06-04 | 2012-03-06 | Ethicon, Inc. | Composition and method for treating post-surgical pain |
JP5740087B2 (ja) | 2006-09-13 | 2015-06-24 | エンハンス スキン プロダクツ,インク. | スキンケア用化粧品組成物およびその製造方法 |
BRPI0721696A2 (pt) * | 2007-05-28 | 2011-06-21 | Vincenzo Massimo Lombardo | composição antiflogìstica e analgésica para uso tópico em uma região de um sistema locomotor animal |
GB0817208D0 (en) * | 2008-09-19 | 2008-10-29 | Pimco 2664 Ltd | Therapeutic apsap compounds and their use |
IT1401351B1 (it) * | 2010-07-28 | 2013-07-18 | Galsor S R L | Composizione farmaceutica a base di una o più frazioni di acido ialuronico o suoi sali in associazione con un inibitore della ialuronidasi e suoi usi in campo medico |
ES2667854T3 (es) * | 2011-07-07 | 2018-05-14 | Holy Stone Healthcare Co., Ltd. | Composición para uso en el tratamiento y la prevención de trastornos relacionados con la inflamación |
EP2545925B1 (de) * | 2011-07-12 | 2018-02-14 | Holy Stone Healthcare Co.,Ltd. | Zusammensetzung enthaltend Hyaluronsäure zur Behandlung und Verhinderung von Schleimhauterkrankungen |
KR20170131542A (ko) * | 2015-03-25 | 2017-11-29 | 가부시키가이샤 화루마쿠리에 고베 | 고분자 약효 성분을 함유한 구강내 시용물 및 구강내에의 고분자 약효 성분의 투여 방법 |
US11793783B2 (en) | 2015-08-05 | 2023-10-24 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
US11684567B2 (en) * | 2015-08-05 | 2023-06-27 | Cmpd Licensing, Llc | Compositions and methods for treating an infection |
US11633352B2 (en) | 2018-01-09 | 2023-04-25 | E2Bio Life Science, LLC | Diclofenac and hyaluronic acid combination treatment for oral leukpoplakia |
WO2020117546A1 (en) * | 2018-12-03 | 2020-06-11 | Samuel Asculai | Pharmaceutical formulations and compositions suitable to treat mucositis |
WO2020160344A1 (en) * | 2019-02-01 | 2020-08-06 | Ehrenpreis Eli D | Diclofenac and hyaluronic acid combination treatment for oral leukpoplakia |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4141973A (en) * | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
IT1229075B (it) * | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico |
NO169637C (no) * | 1983-10-11 | 1992-07-22 | Fidia Spa | Fremgangsmaate for fremstilling av terapeutisk aktive hyaluronsyre-fraksjoner |
US5202431A (en) * | 1985-07-08 | 1993-04-13 | Fidia, S.P.A. | Partial esters of hyaluronic acid |
JPS63101332A (ja) * | 1986-10-17 | 1988-05-06 | Sato Seiyaku Kk | 経口投与用徐放性製剤 |
CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
JP2951681B2 (ja) * | 1990-02-23 | 1999-09-20 | 株式会社資生堂 | 経粘膜投与用薬剤組成物 |
US5910489A (en) * | 1990-09-18 | 1999-06-08 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and NSAIDS |
CA2061703C (en) * | 1992-02-20 | 2002-07-02 | Rudolf E. Falk | Formulations containing hyaluronic acid |
CA2061566C (en) * | 1992-02-20 | 2002-07-09 | Rudolf E. Falk | Treatment of disease employing hyaluronic acid and nsaids |
US6017900A (en) * | 1991-07-03 | 2000-01-25 | Hyal Pharmaceutical Corporation | Topical composition containing hyaluronic acid and nsaids |
CA2094203A1 (en) * | 1993-04-16 | 1994-10-17 | Derek A. Willoughby | Inhibition of angiogenesis |
JPH0717870A (ja) * | 1993-06-29 | 1995-01-20 | Toshiko Yamamoto | トローチ剤 |
-
1995
- 1995-07-18 CA CA002154103A patent/CA2154103C/en not_active Expired - Lifetime
-
1996
- 1996-07-18 AU AU63519/96A patent/AU719257B2/en not_active Expired
- 1996-07-18 ES ES96922722T patent/ES2176468T3/es not_active Expired - Lifetime
- 1996-07-18 US US08/981,602 patent/US6159955A/en not_active Expired - Lifetime
- 1996-07-18 AT AT96922722T patent/ATE217197T1/de active
- 1996-07-18 DE DE69621132T patent/DE69621132T2/de not_active Expired - Lifetime
- 1996-07-18 WO PCT/CA1996/000488 patent/WO1997003699A1/en active IP Right Grant
- 1996-07-18 JP JP50612097A patent/JP4194653B2/ja not_active Expired - Fee Related
- 1996-07-18 EP EP96922722A patent/EP0839052B1/de not_active Expired - Lifetime
- 1996-07-18 NZ NZ312073A patent/NZ312073A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ATE217197T1 (de) | 2002-05-15 |
US6159955A (en) | 2000-12-12 |
DE69621132T2 (de) | 2002-10-31 |
JP4194653B2 (ja) | 2008-12-10 |
AU6351996A (en) | 1997-02-18 |
NZ312073A (en) | 2000-02-28 |
AU719257B2 (en) | 2000-05-04 |
CA2154103A1 (en) | 1997-01-19 |
ES2176468T3 (es) | 2002-12-01 |
WO1997003699A1 (en) | 1997-02-06 |
JPH11514967A (ja) | 1999-12-21 |
EP0839052A1 (de) | 1998-05-06 |
EP0839052B1 (de) | 2002-05-08 |
CA2154103C (en) | 1998-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69621132D1 (de) | Verwendung von hyaluronsäure und eines nsaid zur herstellung eines arzneimittels zur behandlung von krankheiten der mucosa | |
DE69507029T2 (de) | Pharmazeutische zusammensetzungen enthaltend einen opiat antagonist und calcium salze, ihre verwendung zur behandlung von endorphin-vermittelten krankheiten | |
DE69913665D1 (de) | Verwendung von follistatin zur herstellung eines arzneimittels zur behandlung von muskuläre krankheiten | |
DE69526937D1 (de) | Verwendung von methanbisphosphonsäurederivaten zur behandlung von aufgelockerten prothesen | |
DE69903750T2 (de) | Verwendung von langkettigen n-alkyl derivaten von deoxynojirimycin zur herstellung eines medikaments zur behandlung von mit glykolipiden akkumulation zusammenhängenden krankheiten | |
ATE204174T1 (de) | Verwendung von teilchen eines bioverträglichen und bioresorbierbaren kalziumsalzes als wirkstoff in der herstellung eines arzneimittels zur lokalen behandlung von entkalkungskrankheiten | |
DE69417733D1 (de) | Verfahren zur hemmung des knochenschwundes mit 3,4-diarylchroman | |
ATE144420T1 (de) | Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen | |
DE69636343D1 (de) | Verwendung von glu-trp dipeptiden zur herstellung eines arzneimittels zur behandlung von verschiedenen gefässneubildung-assozierten erkrankungen | |
PT881908E (pt) | Utilizacao dos factores de crescimento de fibroblasto para estimular o crescimento osseo | |
ATE146677T1 (de) | Pharmazeutische formulierung zur behandlung der nicotinabhängigkeit | |
ATE309795T1 (de) | Acetylcholinesteraseinhibitoren zur behandlung und diagnose von atemstörungen während des schlafes | |
DE69515038T2 (de) | Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung viraler erkrankungen | |
ATE252897T1 (de) | Verwendung von p-aminophenolderivaten zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von neurodegenerativen erkrankungen | |
DE59508961D1 (de) | Verwendung von weihrauch zur behandlung der alzheimer-krankheit | |
DE69516110T2 (de) | Verwendung von riluzol zur behandlung mitochondrialer erkrankungen | |
FI971127A (fi) | 2,4-diaminopyrimidiini-3-oksidin tai jonkin sen suolan käyttö kollageenin kypsymis- ja rakentumishäiriöiden hoitamiseen | |
HUP9902135A2 (hu) | (+)-alfa-(2,3-Dimetoxi-fenil)-1-[2-(4-fluor-fenil)-etil]-4-piperidin-metanol alkalmazása depresszív és bipoláris rendellenességek kezelésére alkalmas gyógyszerkészítmény előállítására | |
DE69531150D1 (de) | Verwendung von biopolymeren zur behandlung der muskeln | |
ATE194076T1 (de) | Verwendung von n,s-diacetylcystein-ethylester (dacee) zur herstellung eines medikaments zur behandlung viraler erkrankungen | |
DE69525631T2 (de) | Verwendung von prostaglandinen zur herstellung eines arzneimittels zur prävention und behandlung des sekundären katarakts | |
DE69421705T2 (de) | Verwendung von Efaroxan und dessen Derivaten zur Herstellung eines Arzneimittels zur Behandlung neurogenerativer Erkrankungen | |
DE69832796D1 (de) | Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen | |
ATE203671T1 (de) | Imidazolochinoxalinone zur behandlung zentralnervöser erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |